A detailed history of Jackson Hole Capital Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 30,294 shares of GILD stock, worth $2.67 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
30,294
Previous 23,096 31.17%
Holding current value
$2.67 Million
Previous $1.69 Million 22.89%
% of portfolio
0.46%
Previous 0.39%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $454,553 - $524,590
7,198 Added 31.17%
30,294 $2.08 Million
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $250,816 - $305,864
3,504 Added 17.88%
23,096 $1.69 Million
Q4 2023

Feb 02, 2024

BUY
$73.27 - $83.09 $90,928 - $103,114
1,241 Added 6.76%
19,592 $1.59 Million
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $29,206 - $31,864
395 Added 2.2%
18,351 $1.38 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $45,453 - $51,846
-598 Reduced 3.22%
17,956 $1.38 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $9,045 - $10,305
117 Added 0.63%
18,554 $1.54 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $13,087 - $18,788
-210 Reduced 1.13%
18,437 $1.58 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $13,515 - $15,438
227 Added 1.23%
18,647 $1.15 Million
Q2 2022

Jul 27, 2022

BUY
$57.72 - $65.01 $75,497 - $85,033
1,308 Added 7.64%
18,420 $1.14 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $144,742 - $181,377
2,499 Added 17.1%
17,112 $1.02 Million
Q4 2021

Feb 02, 2022

BUY
$64.88 - $73.64 $120,157 - $136,381
1,852 Added 14.51%
14,613 $1.06 Million
Q3 2021

Nov 09, 2021

BUY
$67.69 - $73.03 $121,232 - $130,796
1,791 Added 16.33%
12,761 $891,000
Q2 2021

Jul 28, 2021

BUY
$63.47 - $69.35 $2,983 - $3,259
47 Added 0.43%
10,970 $755,000
Q1 2021

May 07, 2021

BUY
$60.0 - $68.46 $85,140 - $97,144
1,419 Added 14.93%
10,923 $706,000
Q4 2020

Feb 05, 2021

BUY
$56.65 - $64.55 $7,137 - $8,133
126 Added 1.34%
9,504 $554,000
Q3 2020

Nov 03, 2020

BUY
$62.1 - $78.08 $30,863 - $38,805
497 Added 5.6%
9,378 $593,000
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $13,599 - $15,792
188 Added 2.16%
8,881 $683,000
Q3 2019

Nov 07, 2019

BUY
$62.51 - $69.0 $79,637 - $87,906
1,274 Added 17.17%
8,693 $551,000
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $100,353 - $112,534
1,622 Added 27.98%
7,419 $501,000
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $43,771 - $49,035
700 Added 13.73%
5,797 $377,000
Q4 2018

Feb 11, 2019

BUY
$60.54 - $79.0 $308,572 - $402,663
5,097 New
5,097 $319,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Jackson Hole Capital Partners, LLC Portfolio

Follow Jackson Hole Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.